Tag:

Abbott Laboratories

Latest Headlines

Latest Headlines

Study: Newest drug-coated stents as effective as bypass surgery in coronary artery disease

The catheter-based insertion of one of the latest generation of drug-coated stents is just as effective as bypass surgery in treating coronary artery disease, according to a study in the latest issue of the New England Journal of Medicine. That was not the case with the prior generations of bare metal or first-generation drug-eluting stents.

Strong dollar expected to undercut medical device company earnings by 6% this year

As one of the country's large exporting industries, the medical device industry has been hit by the appreciation of the U.S. dollar, which makes exports more expensive and imports cheaper. 

To avoid becoming deal bait, Mylan CEO may have to make another big buy

It's been less than a week since Mylan completed its deal with Abbott, scooping up a large chunk of the Illinois company's overseas generics business. But CEO Heather Bresch is already hinting at another big transaction.

Sun Pharma buys GSK's Tasmania opiates business to expand pain offerings

India's top drugmaker, Sun Pharmaceutical Industries, has agreed to buy GlaxoSmithKline's opiates business in Australia, placing it as one of three owners that control the crop and production in Tasmania that is the world's largest legal supplier of pharmaceutical-grade opiates for painkillers.

Israeli device seed firm Rainbow Medical raises $25M from Chinese investors

Rainbow Medical will open an office in Shanghai to help facilitate strategic deals as part of a $25 million cash infusion from investors in China. The firm is an Israeli-based seed investor and incubator specifically for medical device and medical technology startups.

Diabetes devices drag down Abbott in Q4, but 2015 growth expected on FreeStyle Libre in EU

Abbott Laboratories' sales of medical devices slipped by 3.9% to $1.4 billion in the fourth quarter of 2014 over the same period a year earlier. The company is looking to gain traction in medical devices with its entrance into the electrophysiology market with the December completion of its Topera acquisition.

Abbott Labs continues Dx winning streak with bladder cancer biomarker deal

Abbott Laboratories' diagnostics unit charted sizable gains in 2014, and the company is continuing its upward momentum in the new year with an exclusive licensing deal with the Institut Curie.

Justice Department sues Omnicare for rigging kickbacks with Abbott

Once again, long-term care pharmacy Omnicare is at the center of a Department of Justice kickback probe. This time, the drugmaker in focus is Abbott Laboratories. The drug, Depakote.

Abbott snags CE mark for molecular diagnostic platform for sepsis

Abbott Laboratories snagged a CE mark for its molecular diagnostic platform for blood-related infections, continuing its diagnostics winning streak and moving the company one step closer to securing stateside approval for its product.

What's in a Big Pharma name? Abbott aims to find out with international branding push

Abbott Laboratories is hitching its wagon to growth in emerging markets, rolling out an expanded branding campaign to cozy up with consumers and amp up its presence abroad.